|
Leader
|
|
|
00000nz a2200037n 45 0 |
|
001
|
|
|
WKP|Q28754455
(VIAF cluster)
(Authority/Source Record)
|
|
003
|
|
|
WKP |
|
005
|
|
|
20241221010829.0 |
|
008
|
|
|
241221nneanz||abbn n and d |
|
035
|
|
|
‡a
(WKP)Q28754455
|
|
024
|
|
|
‡a
0000-0002-5036-7607
‡2
orcid
|
|
024
|
|
|
‡a
6506108402
‡2
scopus
|
|
035
|
|
|
‡a
(OCoLC)Q28754455
|
|
046
|
|
|
‡s
19000000
|
|
100
|
0 |
|
‡a
Estela Escribano-Romero
‡c
researcher
‡9
en
|
|
375
|
|
|
‡a
2
‡2
iso5218
|
|
400
|
0 |
|
‡a
Estela Escribano-Romero
‡c
wetenschapper
‡9
nl
|
|
400
|
0 |
|
‡a
Estela Escribano-Romero
‡c
investigadora
‡9
ast
|
|
400
|
0 |
|
‡a
Estela Escribano-Romero
‡c
ricercatrice
‡9
it
|
|
400
|
0 |
|
‡a
Estela Escribano-Romero
‡c
investigadora
‡9
es
|
|
670
|
|
|
‡a
Author's A recombinant DNA vaccine protects mice deficient in the alpha/beta interferon receptor against lethal challenge with Usutu virus
|
|
670
|
|
|
‡a
Author's A Recombinant Subviral Particle-Based Vaccine Protects Magpie
|
|
670
|
|
|
‡a
Author's A Recombinant Subviral Particle-Based Vaccine Protects Magpie (Pica pica) Against West Nile Virus Infection.
|
|
670
|
|
|
‡a
Author's A single amino acid substitution in the core protein of West Nile virus increases resistance to acidotropic compounds
|
|
670
|
|
|
‡a
Author's A Vaccine Based on a Modified Vaccinia Virus Ankara Vector Expressing Zika Virus Structural Proteins Controls Zika Virus Replication in Mice
|
|
670
|
|
|
‡a
Author's Characterization of hepatitis E virus recombinant ORF2 proteins expressed by vaccinia viruses
|
|
670
|
|
|
‡a
Author's Current Progress of Avian Vaccines Against West Nile Virus
|
|
670
|
|
|
‡a
Author's El virus de la hepatitis E: implicaciones zoonóticas
|
|
670
|
|
|
‡a
Author's Evaluation of an enzyme-linked immunosorbent assay for detection of West Nile virus infection based on a recombinant envelope protein produced in Trichoplusia ni larvae.
|
|
670
|
|
|
‡a
Author's Experimental North American West Nile Virus Infection in the Red-legged Partridge (Alectoris rufa).
|
|
670
|
|
|
‡a
Author's Expression and Immunoreactivities of Hepatitis E Virus Genotype 3 Open Reading Frame-2
|
|
670
|
|
|
‡a
Author's Expression and Immunoreactivities of Hepatitis E Virus Genotype 3 Open Reading Frame-2 (ORF-2) Recombinant Proteins Expressed in Insect Cells
|
|
670
|
|
|
‡a
Author's Extinction of West Nile virus by Favipiravir through lethal mutagenesis.
|
|
670
|
|
|
‡a
Author's First serological evidence of West Nile virus activity in horses in Serbia.
|
|
670
|
|
|
‡a
Author's First Serological Study of Hepatitis E Virus Infection in Backyard Pigs from Serbia
|
|
670
|
|
|
‡a
Author's First TBEV serological screening in Flemish wild boar.
|
|
670
|
|
|
‡a
Author's Heparan sulphate mediates swine vesicular disease virus attachment to the host cell
|
|
670
|
|
|
‡a
Author's High susceptibility of magpie
|
|
670
|
|
|
‡a
Author's High susceptibility of magpie (Pica pica) to experimental infection with lineage 1 and 2 West Nile virus.
|
|
670
|
|
|
‡a
Author's Host-Directed Antivirals: a Realistic Alternative to Fight Zika Virus
|
|
670
|
|
|
‡a
Author's Infection with Usutu virus induces an autophagic response in mammalian cells.
|
|
670
|
|
|
‡a
Author's Limited susceptibility of mice to Usutu virus (USUV) infection and induction of flavivirus cross-protective immunity.
|
|
670
|
|
|
‡a
Author's Low Immune Cross-Reactivity between West Nile Virus and a Zika Virus Vaccine Based on Modified Vaccinia Virus Ankara
|
|
670
|
|
|
‡a
Author's Maternal transfer of antibodies to the offspring after mice immunization with insect larvae-derived recombinant hepatitis E virus ORF-2 proteins.
|
|
670
|
|
|
‡a
Author's Molecular cloning, expression and immunological analysis of the capsid precursor polypeptide (P1) from swine vesicular disease virus
|
|
670
|
|
|
‡a
Author's More recent swine vesicular disease virus isolates retain binding to coxsackie-adenovirus receptor, but have lost the ability to bind human decay-accelerating factor (CD55).
|
|
670
|
|
|
‡a
Author's Oculopathologic findings in flavivirus-infected gallinaceous birds.
|
|
670
|
|
|
‡a
Author's Pregnancy increases the risk of mortality in West Nile virus-infected mice.
|
|
670
|
|
|
‡a
Author's Prevalence of hepatitis E virus (HEV) antibodies in Serbian blood donors.
|
|
670
|
|
|
‡a
Author's Prevalence of neutralizing antibodies against West Nile virus
|
|
670
|
|
|
‡a
Author's Prevalence of neutralizing antibodies against West Nile virus (WNV) in monkeys (Ateles geoffroyi and Alouatta pigra) and crocodiles (Crocodylus acutus and C. acutus-C. moreletti hybrids) in Mexico.
|
|
670
|
|
|
‡a
Author's Protection against West Nile virus infection in mice after inoculation with type I interferon-inducing RNA transcripts.
|
|
670
|
|
|
‡a
Author's Protection of a single dose west nile virus recombinant subviral particle vaccine against lineage 1 or 2 strains and analysis of the cross-reactivity with Usutu virus
|
|
670
|
|
|
‡a
Author's Protection of red-legged partridges (Alectoris rufa) against West Nile virus (WNV) infection after immunization with WNV recombinant envelope protein E (rE).
|
|
670
|
|
|
‡a
Author's Recombinant West Nile virus envelope protein E and domain III expressed in insect larvae protects mice against West Nile disease
|
|
670
|
|
|
‡a
Author's Response: Commentary: Zika Virus: the Latest Newcomer
|
|
670
|
|
|
‡a
Author's Stress responses in flavivirus-infected cells: activation of unfolded protein response and autophagy
|
|
670
|
|
|
‡a
Author's Survey of bovine enterovirus in biological and environmental samples by a highly sensitive real-time reverse transcription-PCR.
|
|
670
|
|
|
‡a
Author's Targeting host metabolism by inhibition of acetyl-Coenzyme A carboxylase reduces flavivirus infection in mouse models
|
|
670
|
|
|
‡a
Author's The composition of West Nile virus lipid envelope unveils a role of sphingolipid metabolism in flavivirus biogenesis.
|
|
670
|
|
|
‡a
Author's The continuous spread of West Nile virus (WNV): seroprevalence in asymptomatic horses
|
|
670
|
|
|
‡a
Author's The N-terminal region of the VP1 protein of swine vesicular disease virus contains a neutralization site that arises upon cell attachment and is involved in viral entry
|
|
670
|
|
|
‡a
Author's The soluble form of human respiratory syncytial virus attachment protein differs from the membrane-bound form in its oligomeric state but is still capable of binding to cell surface proteoglycans
|
|
670
|
|
|
‡a
Author's West Nile virus replication requires fatty acid synthesis but is independent on phosphatidylinositol-4-phosphate lipids
|
|
670
|
|
|
‡a
Author's West Nile virus serosurveillance in pigs, wild boars, and roe deer in Serbia
|
|
670
|
|
|
‡a
Author's Widespread distribution of hepatitis E virus in Spanish pig herds.
|
|
670
|
|
|
‡a
Author's Zika virus infection confers protection against West Nile virus challenge in mice
|
|
670
|
|
|
‡a
Author's Zika Virus: the Latest Newcomer
|
|
909
|
|
|
‡a
(scopus) 6506108402
‡9
1
|
|
909
|
|
|
‡a
(orcid) 0000000250367607
‡9
1
|
|
919
|
|
|
‡a
zikavirusthelatestnewcomer
‡A
Zika Virus: the Latest Newcomer
‡9
1
|
|
919
|
|
|
‡a
widespreaddistributionofhepatitisevirusinspanishpigherds
‡A
Widespread distribution of hepatitis E virus in Spanish pig herds.
‡9
1
|
|
919
|
|
|
‡a
westnilevirusserosurveillanceinpigswildboarsandroedeerinserbia
‡A
West Nile virus serosurveillance in pigs, wild boars, and roe deer in Serbia
‡9
1
|
|
919
|
|
|
‡a
westnilevirusreplicationrequiresfattyacidsynthesisbutisindependentonphosphatidylinositol4phosphatelipids
‡A
West Nile virus replication requires fatty acid synthesis but is independent on phosphatidylinositol-4-phosphate lipids
‡9
1
|
|
919
|
|
|
‡a
nterminalregionofthevp1proteinofswinevesiculardiseaseviruscontainsaneutralizationsitethatarisesuponcellattachmentandisinvolvedinviralentry
‡A
The N-terminal region of the VP1 protein of swine vesicular disease virus contains a neutralization site that arises upon cell attachment and is involved in viral entry
‡9
1
|
|
919
|
|
|
‡a
continuousspreadofwestnileviruswnvseroprevalenceinasymptomatichorses
‡A
The continuous spread of West Nile virus (WNV): seroprevalence in asymptomatic horses
‡9
1
|
|
919
|
|
|
‡a
compositionofwestnileviruslipidenvelopeunveilsaroleofsphingolipidmetabolisminflavivirusbiogenesis
‡A
The composition of West Nile virus lipid envelope unveils a role of sphingolipid metabolism in flavivirus biogenesis.
‡9
1
|
|
919
|
|
|
‡a
targetinghostmetabolismbyinhibitionofacetylcoenzymeacarboxylasereducesflavivirusinfectioninmousemodels
‡A
Targeting host metabolism by inhibition of acetyl-Coenzyme A carboxylase reduces flavivirus infection in mouse models
‡9
1
|
|
919
|
|
|
‡a
surveyofbovineenterovirusinbiologicalandenvironmentalsamplesbyahighlysensitiverealtimereversetranscriptionpcr
‡A
Survey of bovine enterovirus in biological and environmental samples by a highly sensitive real-time reverse transcription-PCR.
‡9
1
|
|
919
|
|
|
‡a
stressresponsesinflavivirusinfectedcellsactivationofunfoldedproteinresponseandautophagy
‡A
Stress responses in flavivirus-infected cells: activation of unfolded protein response and autophagy
‡9
1
|
|
919
|
|
|
‡a
responsecommentaryzikavirusthelatestnewcomer
‡A
Response: Commentary: Zika Virus: the Latest Newcomer
‡9
1
|
|
919
|
|
|
‡a
protectionofredleggedpartridgesalectorisrufaagainstwestnileviruswnvinfectionafterimmunizationwithwnvrecombinantenvelopeproteinere
‡A
Protection of red-legged partridges (Alectoris rufa) against West Nile virus (WNV) infection after immunization with WNV recombinant envelope protein E (rE).
‡9
1
|
|
919
|
|
|
‡a
protectionofasingledosewestnilevirusrecombinantsubviralparticlevaccineagainstlineage1or2strainsandanalysisofthecrossreactivitywithusutuvirus
‡A
Protection of a single dose west nile virus recombinant subviral particle vaccine against lineage 1 or 2 strains and analysis of the cross-reactivity with Usutu virus
‡9
1
|
|
919
|
|
|
‡a
protectionagainstwestnilevirusinfectioninmiceafterinoculationwithtype1interferoninducingrnatranscripts
‡A
Protection against West Nile virus infection in mice after inoculation with type I interferon-inducing RNA transcripts.
‡9
1
|
|
919
|
|
|
‡a
prevalenceofneutralizingantibodiesagainstwestnilevirus
‡A
Prevalence of neutralizing antibodies against West Nile virus
‡9
1
|
|
919
|
|
|
‡a
prevalenceofhepatitisevirushevantibodiesinserbianblooddonors
‡A
Prevalence of hepatitis E virus (HEV) antibodies in Serbian blood donors.
‡9
1
|
|
919
|
|
|
‡a
pregnancyincreasestheriskofmortalityinwestnilevirusinfectedmice
‡A
Pregnancy increases the risk of mortality in West Nile virus-infected mice.
‡9
1
|
|
919
|
|
|
‡a
oculopathologicfindingsinflavivirusinfectedgallinaceousbirds
‡A
Oculopathologic findings in flavivirus-infected gallinaceous birds.
‡9
1
|
|
919
|
|
|
‡a
morerecentswinevesiculardiseasevirusisolatesretainbindingtocoxsackieadenovirusreceptorbuthavelosttheabilitytobindhumandecayacceleratingfactorcd55
‡A
More recent swine vesicular disease virus isolates retain binding to coxsackie-adenovirus receptor, but have lost the ability to bind human decay-accelerating factor (CD55).
‡9
1
|
|
919
|
|
|
‡a
maternaltransferofantibodiestotheoffspringaftermiceimmunizationwithinsectlarvaederivedrecombinanthepatitisevirusorf2proteins
‡A
Maternal transfer of antibodies to the offspring after mice immunization with insect larvae-derived recombinant hepatitis E virus ORF-2 proteins.
‡9
1
|
|
919
|
|
|
‡a
infectionwithusutuvirusinducesanautophagicresponseinmammaliancells
‡A
Infection with Usutu virus induces an autophagic response in mammalian cells.
‡9
1
|
|
919
|
|
|
‡a
hostdirectedantiviralsarealisticalternativetofightzikavirus
‡A
Host-Directed Antivirals: a Realistic Alternative to Fight Zika Virus
‡9
1
|
|
919
|
|
|
‡a
1tbevserologicalscreeninginflemishwildboar
‡A
First TBEV serological screening in Flemish wild boar.
‡9
1
|
|
919
|
|
|
‡a
expressionandimmunoreactivitiesofhepatitisevirusgenotype3openreadingframe2orf2recombinantproteinsexpressedininsectcells
‡A
Expression and Immunoreactivities of Hepatitis E Virus Genotype 3 Open Reading Frame-2 (ORF-2) Recombinant Proteins Expressed in Insect Cells
‡9
1
|
|
919
|
|
|
‡a
virusdelahepatitiseimplicacioneszoonoticas
‡A
El virus de la hepatitis E: implicaciones zoonóticas
‡9
1
|
|
919
|
|
|
‡a
vaccinebasedonamodifiedvacciniavirusankaravectorexpressingzikavirusstructuralproteinscontrolszikavirusreplicationinmice
‡A
A Vaccine Based on a Modified Vaccinia Virus Ankara Vector Expressing Zika Virus Structural Proteins Controls Zika Virus Replication in Mice
‡9
1
|
|
919
|
|
|
‡a
singleaminoacidsubstitutioninthecoreproteinofwestnilevirusincreasesresistancetoacidotropiccompounds
‡A
A single amino acid substitution in the core protein of West Nile virus increases resistance to acidotropic compounds
‡9
1
|
|
919
|
|
|
‡a
recombinantdnavaccineprotectsmicedeficientinthealphabetainterferonreceptoragainstlethalchallengewithusutuvirus
‡A
A recombinant DNA vaccine protects mice deficient in the alpha/beta interferon receptor against lethal challenge with Usutu virus
‡9
1
|
|
919
|
|
|
‡a
recombinantsubviralparticlebasedvaccineprotectsmagpie
‡A
A Recombinant Subviral Particle-Based Vaccine Protects Magpie
‡9
1
|
|
919
|
|
|
‡a
prevalenceofneutralizingantibodiesagainstwestnileviruswnvinmonkeysatelesgeoffroyiandalouattapigraandcrocodilescrocodylusacutusand100acutus100morelettihybridsinmexico
‡A
Prevalence of neutralizing antibodies against West Nile virus (WNV) in monkeys (Ateles geoffroyi and Alouatta pigra) and crocodiles (Crocodylus acutus and C. acutus-C. moreletti hybrids) in Mexico.
‡9
1
|
|
919
|
|
|
‡a
characterizationofhepatitisevirusrecombinantorf2proteinsexpressedbyvacciniaviruses
‡A
Characterization of hepatitis E virus recombinant ORF2 proteins expressed by vaccinia viruses
‡9
1
|
|
919
|
|
|
‡a
currentprogressofavianvaccinesagainstwestnilevirus
‡A
Current Progress of Avian Vaccines Against West Nile Virus
‡9
1
|
|
919
|
|
|
‡a
recombinantwestnilevirusenvelopeproteineanddomain3expressedininsectlarvaeprotectsmiceagainstwestniledisease
‡A
Recombinant West Nile virus envelope protein E and domain III expressed in insect larvae protects mice against West Nile disease
‡9
1
|
|
919
|
|
|
‡a
expressionandimmunoreactivitiesofhepatitisevirusgenotype3openreadingframe2
‡A
Expression and Immunoreactivities of Hepatitis E Virus Genotype 3 Open Reading Frame-2
‡9
1
|
|
919
|
|
|
‡a
experimentalnorthamericanwestnilevirusinfectionintheredleggedpartridgealectorisrufa
‡A
Experimental North American West Nile Virus Infection in the Red-legged Partridge (Alectoris rufa).
‡9
1
|
|
919
|
|
|
‡a
extinctionofwestnilevirusbyfavipiravirthroughlethalmutagenesis
‡A
Extinction of West Nile virus by Favipiravir through lethal mutagenesis.
‡9
1
|
|
919
|
|
|
‡a
evaluationofanenzymelinkedimmunosorbentassayfordetectionofwestnilevirusinfectionbasedonarecombinantenvelopeproteinproducedintrichoplusia2larvae
‡A
Evaluation of an enzyme-linked immunosorbent assay for detection of West Nile virus infection based on a recombinant envelope protein produced in Trichoplusia ni larvae.
‡9
1
|
|
919
|
|
|
‡a
1serologicalstudyofhepatitisevirusinfectioninbackyardpigsfromserbia
‡A
First Serological Study of Hepatitis E Virus Infection in Backyard Pigs from Serbia
‡9
1
|
|
919
|
|
|
‡a
highsusceptibilityofmagpie
‡A
High susceptibility of magpie
‡9
1
|
|
919
|
|
|
‡a
heparansulphatemediatesswinevesiculardiseasevirusattachmenttothehostcell
‡A
Heparan sulphate mediates swine vesicular disease virus attachment to the host cell
‡9
1
|
|
919
|
|
|
‡a
solubleformofhumanrespiratorysyncytialvirusattachmentproteindiffersfromthemembraneboundforminitsoligomericstatebutisstillcapableofbindingtocellsurfaceproteoglycans
‡A
The soluble form of human respiratory syncytial virus attachment protein differs from the membrane-bound form in its oligomeric state but is still capable of binding to cell surface proteoglycans
‡9
1
|
|
919
|
|
|
‡a
1serologicalevidenceofwestnilevirusactivityinhorsesinserbia
‡A
First serological evidence of West Nile virus activity in horses in Serbia.
‡9
1
|
|
919
|
|
|
‡a
recombinantsubviralparticlebasedvaccineprotectsmagpiepicapicaagainstwestnilevirusinfection
‡A
A Recombinant Subviral Particle-Based Vaccine Protects Magpie (Pica pica) Against West Nile Virus Infection.
‡9
1
|
|
919
|
|
|
‡a
molecularcloningexpressionandimmunologicalanalysisofthecapsidprecursorpolypeptidep1fromswinevesiculardiseasevirus
‡A
Molecular cloning, expression and immunological analysis of the capsid precursor polypeptide (P1) from swine vesicular disease virus
‡9
1
|
|
919
|
|
|
‡a
zikavirusinfectionconfersprotectionagainstwestnileviruschallengeinmice
‡A
Zika virus infection confers protection against West Nile virus challenge in mice
‡9
1
|
|
919
|
|
|
‡a
lowimmunecrossreactivitybetweenwestnilevirusandazikavirusvaccinebasedonmodifiedvacciniavirusankara
‡A
Low Immune Cross-Reactivity between West Nile Virus and a Zika Virus Vaccine Based on Modified Vaccinia Virus Ankara
‡9
1
|
|
919
|
|
|
‡a
limitedsusceptibilityofmicetousutuvirususuvinfectionandinductionofflaviviruscrossprotectiveimmunity
‡A
Limited susceptibility of mice to Usutu virus (USUV) infection and induction of flavivirus cross-protective immunity.
‡9
1
|
|
919
|
|
|
‡a
highsusceptibilityofmagpiepicapicatoexperimentalinfectionwithlineage1and2westnilevirus
‡A
High susceptibility of magpie (Pica pica) to experimental infection with lineage 1 and 2 West Nile virus.
‡9
1
|
|
946
|
|
|
‡a
a
‡9
1
|
|
996
|
|
|
‡2
LC|n 2021065259
|
|
996
|
|
|
‡2
NTA|316085383
|
|
996
|
|
|
‡2
DNB|1034371649
|
|
996
|
|
|
‡2
SUDOC|171195345
|
|
996
|
|
|
‡2
BNF|17838562
|
|
996
|
|
|
‡2
ISNI|0000000403499062
|
|
996
|
|
|
‡2
PLWABN|9810589436305606
|
|
996
|
|
|
‡2
BIBSYS|6072796
|
|
996
|
|
|
‡2
RERO|A003758061
|
|
997
|
|
|
‡a
1900 0 flourished 0000 0
‡9
1
|
